Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 442,474 |
|
|||||
| News | - | ||||||
| Day High | 15.69 | Low High |
|||||
| Day Low | 14.495 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Y mAbs Therapeutics Inc | YMAB | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.23 | 1.54% | 15.14 | 17:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 14.82 | 14.495 | 15.69 | 15.14 | 14.91 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,733 | 442,474 | $ 15.11 | $ 6,687,698 | - | 4.60 - 20.90 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:02:45 | priorref | 266 | $ 15.14 | USD |
Y mAbs Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 663.22M | 43.78M | - | 84.82M | -21.43M | -0.49 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Y mAbs Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical YMAB Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 14.32 | 15.69 | 13.34 | 14.33 | 268,920 | 0.82 | 5.73% |
| 1 Month | 14.00 | 17.49 | 13.34 | 15.20 | 332,877 | 1.14 | 8.14% |
| 3 Months | 9.85 | 20.90 | 9.38 | 14.96 | 390,816 | 5.29 | 53.71% |
| 6 Months | 5.36 | 20.90 | 4.69 | 11.50 | 320,560 | 9.78 | 182.46% |
| 1 Year | 6.58 | 20.90 | 4.60 | 9.54 | 287,834 | 8.56 | 130.09% |
| 3 Years | 27.71 | 39.8199 | 2.70 | 11.39 | 399,895 | -12.57 | -45.36% |
| 5 Years | 25.38 | 55.36 | 2.70 | 17.52 | 325,245 | -10.24 | -40.35% |
Y mAbs Therapeutics Description
| Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Its pipeline covers Naxitamab, Omburtamab, GD2-GD3 Vaccine, and others. |
